×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

SAPA-NE | ×ðÁú¿­Ê±¹ÚÃûµÚ25½ìÄê»á£¬²¨Ê¿¶Ù¼û£¡

2023-05-29
|
»á¼ûÁ¿£º

SAPA-NEµÚ25½ìÄê»á.jpg

SAPA-NEµÚ25½ìÄê»á½«ÓÚ6ÔÂ3ÈÕÖØ»ØÏßÏ£¬×ðÁú¿­Ê±ºÜÐÒÔËÔÞÖú´Ë´ÎÄê»áÔ˶¯£¬½ñÄêµÚ25½ìÄê»áÖ÷ÌâÊÇ¡°Poised to Pivot: Build Resilience in a Challenging Market¡±£¬°üÀ¨ÐÂÒ©Ñз¢¡¢AIÖÇÒ©¡¢ÉúÎïÒ½Ò©ÊÖÒÕÁ¢Òì¡¢Ò½Ò©ÐÐҵͶ×Ê¡¢×¢²áÉ걨¼°î¿Ïµ»úÖÆµÈÐÂÇ÷ÊÆµÄ½â¶Á¡£

6ÔÂ3ÈÕÉÏÎ磬×ðÁú¿­Ê±CEO³Â´º÷벩ʿ½«´øÀ´Ñݽ²¡°Medicilon Strategy & 20 Years Experience for Dual Filing of IND to US FDA & China NMPA along with IPO at STAR Market¡±

Medicilon-Strategy-&-20-Years-Experience-for-Dual-Filing-of-IND-to-US-FDA-&-China-NMPA-along-with-IPO-at-STAR-Market.jpg

ÎÒÃÇÆÚ´ýÓëÄú̽ÌÖÎÒÃÇÔÚ»¯Ñ§¡¢ÉúÎïѧ¡¢ÌåÄÚºÍÌåÍ⶯ÎïÄ£×Ó¡¢IND É걨·½ÃæµÈ·½ÃæµÄÄÜÁ¦£¬¼ÓËÙÄúµÄÒ©Îï·¢Ã÷ºÍ¿ª·¢ÍýÏ룡

ʱ¼ä | 6ÔÂ3ÈÕ£¬2023Äê

ËùÔÚ | ÂíÈøÖîÈûÖݽ£ÇÅÊÐ,ÃÀ¹ú

SAPA-NEµÚ25½ìÄê»á

SAPA-NEÊÇλÓÚÐÂÓ¢¸ñÀ¼µÄSAPA·Ö»áÖ®Ò»£¬½¨ÉèÓÚ1998 Äê¡£SAPA-NEÄê»áÊǹ¤ÒµºÍѧÊõÊ×ÄÔͨ¹ýÔÚÉúÃü¿ÆÑ§½ç±¬·¢Æð¾¢Ó°ÏìÀ´·ÖÏíËûÃÇÔÚ¿ÆÑ§¡¢ÊÖÒÕºÍÉÌÒµ·½ÃæµÄ֪ʶ¡¢ÂÄÀúºÍ¿´·¨µÄ¾ø¼Ñƽ̨¡£

ÍÆ¼öÔĶÁ:

×ðÁú¿­Ê±Ð·Ö×ÓÀàÐ;ۺϸ³ÄÜÆ½Ì¨

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿